UnitedHealth Group Incorporated $UNH Stock: USS Investment Management Ltd Reduces Stake

USS Investment Management Ltd reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 2.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 145,185 shares of the healthcare conglomerate’s stock after selling 3,608 shares during the quarter. USS Investment Management Ltd’s holdings in UnitedHealth Group were worth $53,314,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. BlackRock Inc. boosted its holdings in shares of UnitedHealth Group by 4.6% during the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after purchasing an additional 3,395,530 shares during the last quarter. State Street Corp lifted its position in shares of UnitedHealth Group by 0.7% in the second quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate’s stock worth $18,966,555,000 after buying an additional 301,081 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in UnitedHealth Group by 6.1% during the second quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate’s stock valued at $4,449,317,000 after buying an additional 616,723 shares during the last quarter. Wellington Management Group LLP grew its holdings in UnitedHealth Group by 5.8% during the 2nd quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate’s stock valued at $4,436,923,000 after buying an additional 583,536 shares in the last quarter. Finally, Fisher Asset Management LLC increased its stake in UnitedHealth Group by 19.2% in the 3rd quarter. Fisher Asset Management LLC now owns 10,829,637 shares of the healthcare conglomerate’s stock worth $3,975,343,000 after acquiring an additional 1,747,368 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Morgan Stanley raised their target price on shares of UnitedHealth Group from $529.00 to $531.00 and gave the company an “overweight” rating in a report on Tuesday, October 27th. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $526.00 to $487.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 27th. Mizuho boosted their target price on shares of UnitedHealth Group from $493.00 to $500.00 and gave the stock an “outperform” rating in a report on Thursday, October 22nd. New Street Research set a $402.00 target price on shares of UnitedHealth Group in a research report on Friday, October 9th. Finally, JPMorgan Chase & Co. lifted their price target on UnitedHealth Group from $516.00 to $524.00 and gave the stock an “overweight” rating in a research report on Friday, October 16th. Twenty research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $465.70.

View Our Latest Research Report on UNH

UnitedHealth Group News Roundup

Investors following UNH have been watching these news items:

  • Positive Sentiment: UnitedHealth raised its 2026 adjusted earnings outlook for the third time this year, to at least $20.50 per share. Recent premium increases, benefit reductions and exits from less-profitable markets helped lift its health-insurance operating margin to 3.3%. UnitedHealth Keeps Raising Guidance
  • Positive Sentiment: Some coverage continues to see long-term growth potential in UnitedHealth, citing Optum’s scale and management’s target of 13%–16% long-term earnings growth. UnitedHealth’s Long-Term Earnings Growth Target
  • Negative Sentiment: The main near-term headwind is a proposed CMS rule that would tighten Medicare Advantage audits and potentially allow recovery of overpayments dating back to 2018. Investors are concerned about the possible financial exposure; CMS estimates industry-wide recoveries could be substantial, but UnitedHealth’s share is not yet clear. The proposal has dragged down managed-care peers as well. Why UnitedHealth and Other Medicare Advantage Insurers Are Falling

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $330.58 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.74. The stock has a market capitalization of $296.21 billion, a price-to-earnings ratio of 18.88, a PEG ratio of 1.27 and a beta of 0.51. The firm’s 50 day simple moving average is $389.42 and its 200-day simple moving average is $367.27. UnitedHealth Group Incorporated has a 12 month low of $255.96 and a 12 month high of $461.62.

UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The firm had revenue of $112.72 billion during the quarter, compared to analysts’ expectations of $111.31 billion. During the same period in the previous year, the business posted $2.59 EPS. The business’s revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Analysts expect that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be given a dividend of $2.32 per share. The ex-dividend date is Monday, December 7th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.8%. UnitedHealth Group’s dividend payout ratio (DPR) is 53.00%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

See Also

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.